American Journal of Transplantation · 2018 · 132 citations · 17 references
MedicinePharmacologyPharmacotherapyDiabetologyKidney TransplantationTransplant SurgeryDiabetes ManagementDiabetes MellitusDiabetes PharmacotherapyImmunosuppression In Kidney TransplantationSodium-glucose Cotransporter 2 InhibitorsTransplant PharmacologyBlood Glucose RegulationImpaired Insulin SensitivityInsulin Sensitivity IndicesKidney Transplant PharmacotherapyMetabolic Complications After TransplantationPost-transplant HyperglycemiaSodium-glucose CotransportSodium-glucose Cotransporter 2 Inhibition
17
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey et al. · New England Journal of Medicine · 2017 · 7.8K citations · Full text
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner, Silvio E. Inzucchi, John M. Lachin et al. · New England Journal of Medicine · 2016 · 3.6K citations · Full text